[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@FiercePharma Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::18294275.png) @FiercePharma FiercePharma

FiercePharma posts on X about breast cancer, $8750t, white house, $4503t the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::18294275/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::18294275/c:line/m:interactions.svg)

- X Week XXXXXX +42%
- X Month XXXXXX +51%
- X Months XXXXXXX -XX%
- X Year XXXXXXX -XXXX%

### Mentions: XX [#](/creator/twitter::18294275/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::18294275/c:line/m:posts_active.svg)

- X Week XX +56%
- X Month XX +9.40%
- X Months XXX -XX%
- X Year XXX +31%

### Followers: XXXXXX [#](/creator/twitter::18294275/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::18294275/c:line/m:followers.svg)

- X Week XXXXXX +0.05%
- X Month XXXXXX +0.22%
- X Months XXXXXX +0.95%
- X Year XXXXXX +0.53%

### CreatorRank: XXXXXXX [#](/creator/twitter::18294275/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::18294275/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::18294275/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX%

**Social topic influence**
[breast cancer](/topic/breast-cancer) #529, [$8750t](/topic/$8750t) #19, [white house](/topic/white-house) 1.3%, [$4503t](/topic/$4503t) 1.3%, [$124m](/topic/$124m) 1.3%, [trumps](/topic/trumps) 1.3%, [sanofi](/topic/sanofi) 1.3%, [novartis](/topic/novartis) 1.3%, [fatal](/topic/fatal) 1.3%, [$3b](/topic/$3b) XXX%

**Top accounts mentioned or mentioned by**
[@persimmonti](/creator/undefined) [@conkers3](/creator/undefined) [@daviddin](/creator/undefined) [@mateosagan](/creator/undefined) [@astellasus](/creator/undefined) [@lux_capital](/creator/undefined) [@polaronfinance](/creator/undefined) [@smallcapbob2](/creator/undefined) [@biogerontology](/creator/undefined) [@alnylam](/creator/undefined) [@healthcarewen](/creator/undefined) [@jacks24450](/creator/undefined) [@boback](/creator/undefined) [@disgustedbuthpl](/creator/undefined) [@snackbiotech](/creator/undefined) [@independentsol4](/creator/undefined)

**Top assets mentioned**
[Sanofi (SNY)](/topic/sanofi) [Novartis AG (NVS)](/topic/novartis)
### Top Social Posts [#](/creator/twitter::18294275/posts)
---
Top posts by engagements in the last XX hours

"AstraZeneca CEO visits White House to formalize MFN agreement with Trump"  
[X Link](https://x.com/FiercePharma/status/1977790274517586167) [@FiercePharma](/creator/x/FiercePharma) 2025-10-13T17:35Z 99.9K followers, 2970 engagements


"Pfizer and Astellas' Padcev plus Keytruda delivers 'breakthrough' win in new bladder cancer use"  
[X Link](https://x.com/FiercePharma/status/1955337237056336244) [@FiercePharma](/creator/x/FiercePharma) 2025-08-12T18:35Z 99.9K followers, 2113 engagements


"Merck's Keytruda follows primary endpoint win in ovarian cancer study with OS triumph"  
[X Link](https://x.com/FiercePharma/status/1978915348536869266) [@FiercePharma](/creator/x/FiercePharma) 2025-10-16T20:06Z 99.9K followers, 2469 engagements


"AstraZeneca Daiichi unleash Enhertu's 2-fisted power aiming to reshape early breast cancer landscape. #ESMO25"  
[X Link](https://x.com/FiercePharma/status/1979557754680529175) [@FiercePharma](/creator/x/FiercePharma) 2025-10-18T14:38Z 99.9K followers, XXX engagements


"Biogen told to pay $124M in patent dispute with Genentech"  
[X Link](https://x.com/FiercePharma/status/1975610321210425731) [@FiercePharma](/creator/x/FiercePharma) 2025-10-07T17:13Z 99.9K followers, 1941 engagements


"Boehringer's Jascayd is the first new drug to break into the idiopathic pulmonary fibrosis field in more than a decade"  
[X Link](https://x.com/FiercePharma/status/1976303750621823059) [@FiercePharma](/creator/x/FiercePharma) 2025-10-09T15:08Z 99.9K followers, 2307 engagements


"Merck KGaAs EMD Serono strikes MFN deal in Trump's fertility treatment pricing push"  
[X Link](https://x.com/FiercePharma/status/1979272497951576295) [@FiercePharma](/creator/x/FiercePharma) 2025-10-17T19:45Z 99.9K followers, 1797 engagements


"Sanofi gets one thumbs up one thumbs down from Europe's CHMP"  
[X Link](https://x.com/FiercePharma/status/1979275472891732235) [@FiercePharma](/creator/x/FiercePharma) 2025-10-17T19:57Z 99.9K followers, 2300 engagements


"Regeneron's Libtayo gains 'practice-changing' skin cancer label expansion"  
[X Link](https://x.com/FiercePharma/status/1976334887058624847) [@FiercePharma](/creator/x/FiercePharma) 2025-10-09T17:12Z 99.9K followers, 2662 engagements


"Pfizer scores again in HER2-positive breast cancer this time with Seagen's Tukysa"  
[X Link](https://x.com/FiercePharma/status/1978194095974859024) [@FiercePharma](/creator/x/FiercePharma) 2025-10-14T20:20Z 99.9K followers, 4397 engagements


"Akeso and Summit Tx's ivonescimab and chemo reduced the risk of progression or death by XX% compared with BeOnes Tevimbra and chemo in Chinese patients with first-line squamous NSCLC according to HARMONi-6 data at #ESMO25"  
[X Link](https://x.com/FiercePharma/status/1979923542956261408) [@FiercePharma](/creator/x/FiercePharma) 2025-10-19T14:52Z 99.9K followers, 3970 engagements


"Pfizer's Lorviqua nabs NICE thumbs up after initial rejection"  
[X Link](https://x.com/FiercePharma/status/1976303590789743006) [@FiercePharma](/creator/x/FiercePharma) 2025-10-09T15:07Z 99.9K followers, 1840 engagements


"Novartis advances IgAN efforts with phase X win for Fabhalta plots FDA filing for full approval"  
[X Link](https://x.com/FiercePharma/status/1978917361747931642) [@FiercePharma](/creator/x/FiercePharma) 2025-10-16T20:14Z 99.9K followers, 2525 engagements


"FDA adds warning to label of J&J Legend's Carvykti for potentially fatal intestinal disorder"  
[X Link](https://x.com/FiercePharma/status/1977793959406739595) [@FiercePharma](/creator/x/FiercePharma) 2025-10-13T17:50Z 99.9K followers, 3038 engagements


"ESMO: Results for AZ's Imfinzi in early bladder cancer type suggest it measures up to Pfizer candidate"  
[X Link](https://x.com/FiercePharma/status/1979285791592317369) [@FiercePharma](/creator/x/FiercePharma) 2025-10-17T20:38Z 99.9K followers, 1922 engagements


"AstraZeneca Daiichi unleash Enhertu's 2-fisted power aiming to reshape early breast cancer landscape. #ESMO25"  
[X Link](https://x.com/FiercePharma/status/1979559794106331391) [@FiercePharma](/creator/x/FiercePharma) 2025-10-18T14:46Z 99.9K followers, 2120 engagements


"Merck's Keytruda becomes part of the first immune checkpoint inhibitor-based regimen to prove a survival benefit in ovarian cancer #ESMO25"  
[X Link](https://x.com/FiercePharma/status/1979578145545097318) [@FiercePharma](/creator/x/FiercePharma) 2025-10-18T15:59Z 99.9K followers, 2206 engagements


"Merck grows again in Va. with $3B small-molecule drug plant part of planned $70B US outlay"  
[X Link](https://x.com/FiercePharma/status/1980362234749747400) [@FiercePharma](/creator/x/FiercePharma) 2025-10-20T19:55Z 99.9K followers, 1307 engagements


"ESMO: Akeso Summit's ivonescimab beats PD-1 in first chemo combo win in 1st-line NSCLC"  
[X Link](https://x.com/FiercePharma/status/1980362312352690308) [@FiercePharma](/creator/x/FiercePharma) 2025-10-20T19:55Z 99.9K followers, 1327 engagements